Clinical Trials Browser

Phase 2 × STA 9090 × Dermatologic × Clear all

NCT01200238 2018-10-18

STA-9090(Ganetespib) in Metastatic Ocular Melanoma

Phase 2 Completed

17 enrolled 12 charts

Uveal Melanoma

NCT01551693 2017-04-12

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Terminated

3 enrolled 7 charts

Melanoma, Neoplasm Metastasis